SCHEMBL14992467

SCHEMBL14992467

Cc1cc(I)cc(F)c1CC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2463078 0.86
SCHEMBL14992608 0.78 IMPDH2 (0.32)
SCHEMBL2464673 0.78 IMPDH2 (0.31)
SCHEMBL13264166 0.76 HTR2A (0.30)
SCHEMBL22443154 0.69 HSP90AB1 (0.39)
SCHEMBL1124861 0.69 HRH3 (0.36)
SCHEMBL1428232 0.69 ERN1 (0.40)
SCHEMBL14992928 0.68 TAAR1 (0.38)
SCHEMBL2370050 0.67 DAO (0.45)
SCHEMBL20919064 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2785714-A1 IMPROVED MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR Taivex Therapeutics Corporation (TW) 2014-10-08 EP disclosed
WO-2013082324-A1 IMPROVED MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR TAIVEX THERAPEUTICS CORPORATION (TW) 2013-06-06 WO disclosed